Buprenorphine Hydrochloride And Naloxone Hydrochloride Dihydrate Tablet
Product Images NDC 0904-7009

Product Visual Gallery

This gallery contains 5 technical images submitted to the FDA as part of the official labeling for Buprenorphine Hydrochloride And Naloxone Hydrochloride Dihydrate (NDC 0904-7009). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Major Pharmaceuticals, these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

959e2dcf 530b 43f3 9916 23c16ccc2c50 00

Packaging label for Major Pharmaceuticals buprenorphine hydrochloride and naloxone hydrochloride dihydrate sublingual tablets USP, 8 mg/2 mg strength. The unit dose packaging includes 50 tablets with prescription-only designation. The label cautions that children accidentally ingesting the medication require emergency care and provides usage and safety information. The labeler information for Major Pharmaceuticals is also displayed with NDC 0904-7010-06.*

FDA Label Image

959e2dcf 530b 43f3 9916 23c16ccc2c50 01

Label for buprenorphine hydrochloride and naloxone hydrochloride dihydrate sublingual tablets USP, 2 mg/0.5 mg strength. The label shows the product's proprietary name, dosage form, unit dose packaging, and that it contains 50 tablets. The label indicates the product is Rx only, includes dispensing and emergency care instructions, and lists Major Pharmaceuticals as the labeler. The National Drug Code (NDC) is 0904-7009-06. The label also provides storage instructions and distributor information.*

FDA Label Image

Buprenorphine-medguide-graphic.jpg (Buprenorphine Medguide Graphic)

An instructional illustration showing a person placing a sublingual tablet under their tongue, demonstrating the proper method of administration for buprenorphine hydrochloride and naloxone hydrochloride dihydrate tablets.*

FDA Label Image

Image 02

Chemical structure of buprenorphine hydrochloride, depicting its molecular framework with aromatic rings, hydroxyl groups, and a cyclopropylmethyl group, including the associated hydrochloride (HCl) moiety.*

FDA Label Image

Naloxone-chem-figure.jpg (Naloxone Chem Figure)

Chemical structure of buprenorphine hydrochloride and naloxone hydrochloride dihydrate, showing the molecular framework including rings, hydroxyl groups, and hydrochloride and dihydrate components.*

* About these descriptions: Image descriptions on this page are generated by automated AI analysis of the product label images from the manufacturer's FDA label submission (SPL). They are provided for reference only and may contain errors or omissions. Always rely on the printed label itself and the official FDA labeling, and consult a pharmacist or healthcare professional with any questions about this product.